Status:
NOT_YET_RECRUITING
Evaluation of Clinical Decision Support in Opioid Tapering
Lead Sponsor:
University of Colorado, Denver
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
National Institutes of Health (NIH)
Conditions:
Medication Abuse
Harm Reduction
Eligibility:
All Genders
12-89 years
Brief Summary
The 2022 Center for Disease Control and Prevention (CDC) clinical practice guideline for prescribing opioids for pain recommends that when tapering a patient's opioid dose, doses should be decreased a...
Eligibility Criteria
Inclusion
- Primary care patients being tapered from an opioid. Tapering patients:
- Have an active opioid prescription for more than 3 months and
- Prescribed more than 90 morphine milligram equivalents (MME) per day or
- Co-prescribed an opioid and benzodiazepine or
- Received a reduction in opioid dosage by more than 5% MME per day
Exclusion
- Patients \<12 and \>89
- Patients with active cancer diagnosis in last 1 year
- Patients with hospice care/palliative care order
- Patients with sickle cell disease diagnosis
Key Trial Info
Start Date :
February 1 2026
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
200000 Patients enrolled
Trial Details
Trial ID
NCT06527079
Start Date
February 1 2026
End Date
June 1 2027
Last Update
December 10 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.